Matthew Nicosia - Net Worth and Insider Trading
Matthew Nicosia Net Worth
The estimated net worth of Matthew Nicosia is at least $5 Million dollars as of 2024-05-05. Matthew Nicosia is the CEO, 10% Owner of Vivakor Inc and owns about 4,190,601 shares of Vivakor Inc (VIVK) stock worth over $5 Million. Details can be seen in Matthew Nicosia's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Matthew Nicosia has not made any transactions after 2022-02-17 and currently still holds the listed stock(s).
Transaction Summary of Matthew Nicosia
Matthew Nicosia Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew Nicosia owns 2 companies in total, including Cannapharmarx Inc (CPMD) , and Vivakor Inc (VIVK) .
Click here to see the complete history of Matthew Nicosia’s form 4 insider trades.
Insider Ownership Summary of Matthew Nicosia
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CPMD | Cannapharmarx Inc | 2018-04-20 | director & 10 percent owner |
| VIVK | Vivakor Inc | 2022-02-17 | director |
Matthew Nicosia Latest Holdings Summary
Matthew Nicosia currently owns a total of 1 stock. Matthew Nicosia owns 4,190,601 shares of Vivakor Inc (VIVK) as of February 17, 2022, with a value of $5 Million.
Latest Holdings of Matthew Nicosia
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VIVK | Vivakor Inc | 2022-02-17 | 4,190,601 | 1.27 | 5,322,063 |
Holding Weightings of Matthew Nicosia
Matthew Nicosia Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew Nicosia has made a total of 2 transactions in Vivakor Inc (VIVK) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Vivakor Inc is the acquisition of 320 shares on February 17, 2022, which cost Matthew Nicosia around $944.
Insider Trading History of Matthew Nicosia
- 1
Matthew Nicosia Trading Performance
GuruFocus tracks the stock performance after each of Matthew Nicosia's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Matthew Nicosia is -41.34%. GuruFocus also compares Matthew Nicosia's trading performance to market benchmark return within the same time period. The performance of stocks bought by Matthew Nicosia within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Matthew Nicosia's insider trading performs compared to the benchmark.
Performance of Matthew Nicosia
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -8.06 | | | | | |
| Relative Return to S&P 500(%) | -7.11 | | | | | |
Matthew Nicosia Ownership Network
Matthew Nicosia Owned Company Details
What does Cannapharmarx Inc do?
Who are the key executives at Cannapharmarx Inc?
Matthew Nicosia is the director & 10 percent owner of Cannapharmarx Inc. Other key executives at Cannapharmarx Inc include director & Chief Executive Officer Dominic Colvin , Chief Financial Officer John Hamilton Cassels , and Chief Operating Officer Andrew Clifford Steedman .
Cannapharmarx Inc (CPMD) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Cannapharmarx Inc (CPMD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cannapharmarx Inc (CPMD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Cannapharmarx Inc (CPMD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cannapharmarx Inc Insider Transactions
Matthew Nicosia Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew Nicosia. You might contact Matthew Nicosia via mailing address: 2 Park Plaza, Suite 400, Irvine Ca 92614.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
